Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy

Sponsor
University of Utah (Other)
Overall Status
Terminated
CT.gov ID
NCT03075176
Collaborator
(none)
39
1
4
29.9
1.3

Study Details

Study Description

Brief Summary

This study evaluates the difference in results between eyes that have been treated wavefront optimized laser vision correction (either LASIK or Photorefractive Keratectomy) compared to eyes treated with topography-guided laser vision correction (either LASIK or Photorefractive Keratectomy). Each participant will receive wavefront optimized correction in one eye and topography-guided correction in the other.

Condition or Disease Intervention/Treatment Phase
  • Device: Wavefront optimized LASIK
  • Device: Wavefront optimized Photorefractive Keratectomy
  • Device: Topography-guided LASIK
  • Device: Topography-guided Photorefractive Keratectomy
N/A

Detailed Description

Participants will have an in depth discussion with our refractive surgery coordinator regarding refractive surgery. Patients will choose LASIK or Photorefractive Keratectomy surgery based on our standard pre-operative discussion that is provided to all patients. As is standard for laser refractive candidates, the advantages and disadvantages of LASIK and Photorefractive Keratectomy compared to the other refractive surgical options will be discussed. Following patient selection of their preferred type of refractive procedure they will be randomized as discussed below, and only patients who elect for LASIK or Photorefractive Keratectomy will be included in our study.

Prior to surgery, one eye from each patient will be randomly assigned to receive either Wavefront optimized or Topography Guided treatment. Each patient in the study will have a fellow eye enrolled in the other treatment group. Patients will either receive LASIK treatment or Photorefractive Keratectomy treatment in both eyes but the eyes will be randomized to topography guided or wavefront optimized forms of treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
39 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Each participant will receive wavefront optimized surgery in one eye and topography-guided surgery in the second eye.Each participant will receive wavefront optimized surgery in one eye and topography-guided surgery in the second eye.
Masking:
Single (Participant)
Masking Description:
Participants will be masked as to which type of surgery they receive in either eye.
Primary Purpose:
Treatment
Official Title:
Outcomes of Topography-guided LASIK and Photorefractive Keratectomy Compared to Wavefront Optimized LASIK and Photorefractive Keratectomy
Actual Study Start Date :
Feb 13, 2017
Actual Primary Completion Date :
Aug 12, 2019
Actual Study Completion Date :
Aug 12, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Wavefront optimized LASIK

Participants who chose to have LASIK surgery were assigned to have Wavefront optimized LASIK in one eye and Topography-guided LASIK in the other eye (randomly chosen).

Device: Wavefront optimized LASIK
Wavefront optimized laser vision correction

Device: Topography-guided LASIK
Topography-guided laser vision correction

Active Comparator: Wavefront optimized Photorefractive Keratectomy

Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Wavefront optimized Photorefractive Keratectomy in one eye and Topography-guided Photorefractive Keratectomy in the other eye (randomly chosen).

Device: Wavefront optimized Photorefractive Keratectomy
Wavefront optimized laser vision correction

Device: Topography-guided Photorefractive Keratectomy
Topography-guided laser vision correction

Active Comparator: Topography-guided LASIK

Participants who chose to have LASIK surgery were assigned to have Topography-guided LASIK in one eye and Wavefront optimized LASIK in the other eye (randomly chosen).

Device: Wavefront optimized LASIK
Wavefront optimized laser vision correction

Device: Topography-guided LASIK
Topography-guided laser vision correction

Active Comparator: Topography-guided Photorefractive Keratectomy

Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Topography-guided Photorefractive Keratectomy in one eye and Wavefront optimized Photorefractive Keratectomy in the other eye (randomly chosen).

Device: Wavefront optimized Photorefractive Keratectomy
Wavefront optimized laser vision correction

Device: Topography-guided Photorefractive Keratectomy
Topography-guided laser vision correction

Outcome Measures

Primary Outcome Measures

  1. Change in uncorrected visual acuity from baseline to month 12 [12 months]

    Uncorrected visual acuity will be tested pre-operatively through month 12

Secondary Outcome Measures

  1. Change in contrast sensitivity from baseline to month 3 [3 months]

    Contrast sensitivity will be tested pre-operatively and 3 months post-operatively

Other Outcome Measures

  1. Change in degree of higher order aberrations from baseline to 3 months [3 months]

    Aberrometry measurements will be taken pre-operatively and 3 months post surgery

  2. Change in quality of life score from baseline to 3 months [3 months]

    The validated Quality of Life Impact of Refractive Correction survey will be administered pre-operatively and 3 months post surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All subjects who are deemed suitable candidates for laser refractive surgery after routine refractive surgery screening will be considered eligible for participation in this study.

Subjects must be at least 21 years of age and not pregnant or nursing (due to fluctuations in visual parameters during pregnancy)

Exclusion Criteria:
  • Any patient who is not a suitable candidate for LASIK or PRK will not be included.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Moran Eye Center - Midvalley Location Murray Utah United States 84107

Sponsors and Collaborators

  • University of Utah

Investigators

  • Principal Investigator: Mark Mifflin, MD, University of Utah Moran Eye Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mark Mifflin, Professor, Ophthalmology/Visual Sciences, University of Utah
ClinicalTrials.gov Identifier:
NCT03075176
Other Study ID Numbers:
  • IRB # 95434
First Posted:
Mar 9, 2017
Last Update Posted:
Aug 23, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Mark Mifflin, Professor, Ophthalmology/Visual Sciences, University of Utah
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 23, 2022